Detalles de la búsqueda
1.
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib.
Mod Rheumatol
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801704
2.
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Ann Rheum Dis
; 82(1): 119-129, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36137735
3.
Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies.
Rheumatology (Oxford)
; 60(4): 1708-1716, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33057725
4.
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
Dig Dis Sci
; 66(8): 2732-2743, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816215
5.
Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials.
J Clin Rheumatol
; 27(8): e482-e490, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32826657
6.
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme.
Ann Rheum Dis
; 82(4): 575-577, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720582
7.
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5â years: integrated analysis of data from the global clinical trials.
Ann Rheum Dis
; 76(7): 1253-1262, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28143815
8.
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies.
Rheumatology (Oxford)
; 56(1): 46-57, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028154
9.
Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population.
J Clin Rheumatol
; 23(4): 193-199, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28145906
10.
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs.
Ann Rheum Dis
; 75(7): 1293-301, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275429
11.
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme.
Ann Rheum Dis
; 75(5): 831-41, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25902789
12.
Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
Clin Exp Rheumatol
; 34(1): 32-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26575982
13.
Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
Dig Dis Sci
; 66(9): 3214-3215, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33037970
14.
The Effects of Varying Break Length on Attention and Time on Task.
Hum Factors
; 58(3): 472-81, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26715686
15.
Functional cortical connectivity analysis of mental fatigue unmasks hemispheric asymmetry and changes in small-world networks.
Brain Cogn
; 85: 220-30, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24463002
16.
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
Rheumatol Ther
; 11(3): 583-597, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38488976
17.
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study.
RMD Open
; 10(2)2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609322
18.
EEG alpha activity is associated with individual differences in post-break improvement.
Neuroimage
; 76: 81-9, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23523810
19.
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials.
Arthritis Res Ther
; 25(1): 214, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919780
20.
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start.
Arthritis Res Ther
; 25(1): 185, 2023 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773189